These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21738320)
1. Structure based virtual screening of anticanerous polyphenolic phytocompounds against G-protein coupled receptor and identification of potent antagonist ligand(s) through molecular docking. Pitchai D; Manikkam R; V SL; Singaram R Bioinformation; 2011; 6(6):226-8. PubMed ID: 21738320 [TBL] [Abstract][Full Text] [Related]
2. Going further than Lipinski's rule in drug design. Walters WP Expert Opin Drug Discov; 2012 Feb; 7(2):99-107. PubMed ID: 22468912 [TBL] [Abstract][Full Text] [Related]
3. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone. Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five. Chen X; Li H; Tian L; Li Q; Luo J; Zhang Y J Comput Biol; 2020 Sep; 27(9):1397-1406. PubMed ID: 32031890 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel metallo-β-lactamases inhibitors using ligand-based pharmacophore modelling and structure-based virtual screening. Ezati M; Ahmadi A; Behmard E; Najafi A J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37732367 [TBL] [Abstract][Full Text] [Related]
6. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics. Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103 [TBL] [Abstract][Full Text] [Related]
7. Exploration and evaluation of bioactive phytocompounds against BRCA proteins by Prabhavathi H; Dasegowda KR; Renukananda KH; Lingaraju K; Naika HR J Biomol Struct Dyn; 2021 Sep; 39(15):5471-5485. PubMed ID: 32643536 [TBL] [Abstract][Full Text] [Related]
8. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya. Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965 [TBL] [Abstract][Full Text] [Related]
9. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2. Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation. Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071 [TBL] [Abstract][Full Text] [Related]
11. Molecular docking-based virtual screening, molecular dynamic simulation, and 3-D QSAR modeling of some pyrazolopyrimidine analogs as potent anti-filarial agents. Ugbe FA; Shallangwa GA; Uzairu A; Abdulkadir I In Silico Pharmacol; 2022; 10(1):21. PubMed ID: 36387058 [TBL] [Abstract][Full Text] [Related]
12. Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods. AlZahrani WM; AlGhamdi SA; Zughaibi TA; Rehan M Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215307 [TBL] [Abstract][Full Text] [Related]
13. Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study. Holanda VN; Lima EMA; Silva WVD; Maia RT; Medeiros RL; Ghosh A; Lima VLM; Figueiredo RCBQ J Biomol Struct Dyn; 2022 Aug; 40(12):5462-5480. PubMed ID: 33459182 [TBL] [Abstract][Full Text] [Related]
14. Exploration of Novel PDEδ Inhibitor Based on Pharmacophore and Molecular Docking against KRAS Mutant in Colorectal Cancer. Mouhcine M; Kadil Y; Rahmoune I; Filali H Curr Drug Discov Technol; 2023; 20(4):e160423215830. PubMed ID: 37066770 [TBL] [Abstract][Full Text] [Related]
15. Ligand and Structure-Based Virtual Screening in Combination, to Evaluate Small Organic Molecules as Inhibitors for the XIAP Anti-Apoptotic Protein: The Xanthohumol Hypothesis. Mavra A; Petrou CC; Vlasiou MC Molecules; 2022 Jul; 27(15):. PubMed ID: 35956774 [TBL] [Abstract][Full Text] [Related]
16. Chemical Characterization, Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087 [TBL] [Abstract][Full Text] [Related]
17. Structure-based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates for the SARS-CoV-2 inhibitors. Abchir O; Nour H; Daoui O; Yamari I; ElKhattabi S; El Kouali M; Talbi M; Errougui A; Chtita S Nat Prod Res; 2023 Nov; ():1-8. PubMed ID: 37966948 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz. Jordaan MA; Ebenezer O; Damoyi N; Shapi M Heliyon; 2020 Aug; 6(8):e04642. PubMed ID: 32802982 [TBL] [Abstract][Full Text] [Related]
19. Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study. Kar B; Dehury B; Singh MK; Pati S; Bhattacharya D J Mol Graph Model; 2022 Jul; 114():108192. PubMed ID: 35468453 [TBL] [Abstract][Full Text] [Related]